SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-23-020625
Filing Date
2023-06-09
Accepted
2023-06-08 18:49:03
Documents
85
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 2030640
2 ex23-3.htm EX-23.3 4033
3 ex23-4.htm EX-23.4 4551
4 ex31-3.htm EX-31.3 12150
5 ex31-4.htm EX-31.4 12148
6 ex32-2.htm EX-32.2 9250
  Complete submission text file 0001493152-23-020625.txt   11371873

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE envb-20221231.xsd EX-101.SCH 76862
8 XBRL CALCULATION FILE envb-20221231_cal.xml EX-101.CAL 69050
9 XBRL DEFINITION FILE envb-20221231_def.xml EX-101.DEF 346868
10 XBRL LABEL FILE envb-20221231_lab.xml EX-101.LAB 646048
11 XBRL PRESENTATION FILE envb-20221231_pre.xml EX-101.PRE 501936
79 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 2459458
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38286 | Film No.: 231003362
SIC: 2834 Pharmaceutical Preparations